Astellas Pharma's revenue FY 2014-2023
The revenue of Astellas Pharma Inc. in the fiscal year 2023 amounted to more than 1.6 trillion Japanese yen, the highest number of the past decade. The figures have been constantly increasing from around 1.25 trillion yen in 2014. Established in 1923, Astellas is a Japanese company operating in the business of manufacturing, marketing, and trade of pharmaceuticals.